Company intelligence / Profile preview

Access Pro Medical

Augusta, Georgia, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Access Pro Medical commercially distributes MatriDerm, a single‑use acellular dermal matrix for soft tissue reconstruction and wound management in the U.S.; it is a marketed product supported by clinical publications but the company itself does not appear to run drug clinical trials.

Therapeutic areas: OtherDermatologyOncology
Modalities: DeviceBiologic
Industry: Consumable Medical Devices

Partnerships

MedSkin Solutions Dr. Suwelack (manufacturer of MatriDerm; exclusive U.S. distribution agreement)Solvita (formerly Community Tissue Services) for Maxxeus Burn allograft distribution

Beyond the preview

Go deeper on Access Pro Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Access Pro Medical.

Explore the full profile